Skip to content
Disclosery

DEERFIELD MANAGEMENT COMPANY, L.P.

Follow

13F filer, CIK 1009258, New York, NY

DEERFIELD MANAGEMENT COMPANY, L.P. reported $8,476,379,716 across 82 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-15. Its ten largest share positions make up 50.85% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001213900-26-057678

Period
2026-03-31
Reported value
$8.48B
Holdings
82
Top 10 weight
50.85%
New
12
Sold out
80

Part of the filer group DEERFIELD MANAGEMENT COMPANY, L.P.

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
INDVnew+3,097,790$94.4M
SNDXnew+3,779,900$88.3M
DNTHnew+1,019,813$85.6M
PFEnew+3,040,000$85.4M
GMABnew+2,462,000$66.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
INDIVIOR PLCexited-3,393,063-$122M
NBIXreduced-574,345-$75.7M
RVMDreduced-597,613-$58.1M
PHRexited-1,999,045-$33.8M
VTRexited-354,000-$27.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001213900-26-057678, largest first. % of portfolio is the value over $8,476,379,716, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 19,991,024 shares; 2024Q4: 17,991,024 shares; 2025Q1: 17,991,024 shares; 2025Q2: 17,991,024 shares; 2025Q3: 17,991,024 shares; 2025Q4: 17,248,450 shares; 2026Q1: 17,248,450 shares 17,248,450$1.77B20.85%0Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,744,263 shares; 2024Q4: 2,631,000 shares; 2025Q1: 2,633,862 shares; 2025Q2: 2,640,215 shares; 2025Q3: 9,053,118 shares; 2025Q4: 9,043,903 shares; 2026Q1: 9,043,903 shares 9,043,903$348M4.11%0Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 619,931 shares; 2025Q2: 686,931 shares; 2025Q3: 840,851 shares; 2025Q4: 903,351 shares; 2026Q1: 963,351 shares 963,351$310M3.66%+60,000Timeline
VTRSVIATRIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 23,993,023 shares; 2024Q4: 23,996,036 shares; 2025Q1: 23,991,594 shares; 2025Q2: 24,023,907 shares; 2025Q3: 24,099,083 shares; 2025Q4: 20,206,170 shares; 2026Q1: 20,206,170 shares 20,206,170$273M3.22%0Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 275,226 shares; 2025Q2: 540,626 shares; 2025Q3: 425,993 shares; 2025Q4: 425,993 shares; 2026Q1: 457,000 shares 457,000$271M3.2%+31,007Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,912,692 shares; 2024Q4: 3,258,332 shares; 2025Q1: 3,317,332 shares; 2025Q2: 3,384,072 shares; 2025Q3: 3,650,342 shares; 2025Q4: 2,894,613 shares; 2026Q1: 2,297,000 shares 2,297,000$223M2.64%-597,613Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 733,530 shares; 2025Q4: 1,714,000 shares; 2026Q1: 1,714,000 shares 1,714,000$196M2.31%0Timeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,652,189 shares; 2024Q4: 2,671,921 shares; 2025Q1: 2,671,921 shares; 2025Q2: 3,185,370 shares; 2025Q3: 9,046,000 shares; 2025Q4: 6,447,998 shares; 2026Q1: 5,917,091 shares 5,917,091$194M2.29%-530,907Timeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 21,231,974 shares; 2024Q4: 21,231,974 shares; 2025Q1: 21,231,974 shares; 2025Q2: 21,231,974 shares; 2025Q3: 30,606,974 shares; 2025Q4: 30,606,974 shares; 2026Q1: 35,606,974 shares 35,606,974$160M1.89%+5,000,000Timeline
BKDBROOKDALE SR LIVING INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 15,612,264 shares; 2024Q4: 15,612,264 shares; 2025Q1: 15,612,264 shares; 2025Q2: 15,362,264 shares; 2025Q3: 11,641,642 shares; 2025Q4: 11,637,032 shares; 2026Q1: 11,637,032 shares 11,637,032$159M1.88%0Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,050,000 shares; 2025Q2: 3,348,117 shares; 2025Q3: 3,641,157 shares; 2025Q4: 4,059,695 shares; 2026Q1: 3,722,100 shares 3,722,100$150M1.77%-337,595Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,979,669 shares; 2025Q4: 1,979,669 shares; 2026Q1: 1,979,669 shares 1,979,669$149M1.75%0Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 8,135,804 shares; 2024Q4: 8,144,442 shares; 2025Q1: 5,189,665 shares; 2025Q2: 4,692,000 shares; 2025Q3: 12,169,000 shares; 2025Q4: 14,341,000 shares; 2026Q1: 15,038,000 shares 15,038,000$143M1.69%+697,000Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 140,000 shares; 2025Q3: 1,047,694 shares; 2025Q4: 1,505,872 shares; 2026Q1: 2,703,238 shares 2,703,238$139M1.64%+1,197,366Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,551,718 shares; 2025Q1: 1,743,555 shares; 2025Q2: 2,962,338 shares; 2025Q3: 2,962,338 shares; 2025Q4: 5,932,000 shares; 2026Q1: 7,687,638 shares 7,687,638$139M1.64%+1,755,638Timeline
AHCOADAPTHEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 9,711,410 shares; 2024Q4: 9,711,410 shares; 2025Q1: 9,711,410 shares; 2025Q2: 9,904,895 shares; 2025Q3: 11,477,730 shares; 2025Q4: 11,477,730 shares; 2026Q1: 11,477,730 shares 11,477,730$137M1.61%0Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 901,750 shares; 2024Q4: 4,314,340 shares; 2025Q1: 4,103,957 shares; 2025Q2: 5,115,953 shares; 2025Q3: 4,266,693 shares; 2025Q4: 4,164,789 shares; 2026Q1: 4,264,789 shares 4,264,789$137M1.61%+100,000Timeline
ACHCACADIA HEALTHCARE COMPANY INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 17,673 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,189,000 shares; 2025Q4: 4,520,000 shares; 2026Q1: 4,520,000 shares 4,520,000$106M1.25%0Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 26,439 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 993,000 shares; 2025Q4: 1,832,946 shares; 2026Q1: 1,573,297 shares 1,573,297$98.6M1.16%-259,649Timeline
CPRXCATALYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 6,229,634 shares; 2024Q4: 3,133,011 shares; 2025Q1: 3,422,149 shares; 2025Q2: 2,879,476 shares; 2025Q3: 4,974,767 shares; 2025Q4: 4,911,161 shares; 2026Q1: 3,943,600 shares 3,943,600$97.6M1.15%-967,561Timeline
INDVINDIVIOR PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,097,790 shares 3,097,790$94.4M1.11%newTimeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 542,020 shares; 2025Q3: 542,020 shares; 2025Q4: 542,020 shares; 2026Q1: 1,615,696 shares 1,615,696$94M1.11%+1,073,676Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,031,700 shares; 2024Q4: 2,017,464 shares; 2025Q1: 2,017,464 shares; 2025Q2: 2,017,464 shares; 2025Q3: 2,442,464 shares; 2025Q4: 3,126,042 shares; 2026Q1: 3,126,042 shares 3,126,042$88.3M1.04%0Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,779,900 shares 3,779,900$88.3M1.04%newTimeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,540,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,906,946 shares; 2026Q1: 4,146,813 shares 4,146,813$86.8M1.02%+1,239,867Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,019,813 shares 1,019,813$85.6M1.01%newTimeline
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,347,296 shares; 2025Q2: 4,306,264 shares; 2025Q3: 3,303,790 shares; 2025Q4: not reported; 2026Q1: 3,040,000 shares 3,040,000$85.4M1.01%newTimeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,316,590 shares; 2024Q4: 862,000 shares; 2025Q1: 1,489,000 shares; 2025Q2: 1,167,802 shares; 2025Q3: 1,184,345 shares; 2025Q4: 1,184,345 shares; 2026Q1: 610,000 shares 610,000$80.4M0.95%-574,345Timeline
DAWNDAY ONE BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,617,713 shares; 2024Q4: 2,596,033 shares; 2025Q1: 2,960,740 shares; 2025Q2: 3,723,131 shares; 2025Q3: 4,705,413 shares; 2025Q4: 3,723,131 shares; 2026Q1: 3,723,131 shares 3,723,131$79.8M0.94%0Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 6,465,777 shares; 2024Q4: 7,964,000 shares; 2025Q1: 7,964,000 shares; 2025Q2: 7,964,000 shares; 2025Q3: 7,964,000 shares; 2025Q4: 13,569,000 shares; 2026Q1: 13,569,000 shares 13,569,000$74.1M0.87%0Timeline
EHABENHABIT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,997,746 shares; 2024Q4: 5,010,972 shares; 2025Q1: 4,997,746 shares; 2025Q2: 4,779,864 shares; 2025Q3: 4,747,746 shares; 2025Q4: 4,747,746 shares; 2026Q1: 4,747,746 shares 4,747,746$66.9M0.79%0Timeline
GMABGENMAB A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,462,000 shares 2,462,000$66.1M0.78%newTimeline
BIOBIO RAD LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 151,575 shares; 2024Q4: 151,644 shares; 2025Q1: 226,070 shares; 2025Q2: 226,070 shares; 2025Q3: 226,070 shares; 2025Q4: 226,070 shares; 2026Q1: 226,070 shares 226,070$63M0.74%0Timeline
LNTHLANTHEUS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 240,218 shares; 2024Q4: 240,218 shares; 2025Q1: 240,218 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 827,999 shares; 2026Q1: 827,999 shares 827,999$62.8M0.74%0Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 11,077,927 shares; 2024Q4: 10,514,657 shares; 2025Q1: 10,514,657 shares; 2025Q2: 9,724,508 shares; 2025Q3: 7,503,812 shares; 2025Q4: 7,503,812 shares; 2026Q1: 7,503,812 shares 7,503,812$60.3M0.71%0Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,823,500 shares; 2026Q1: 1,823,500 shares 1,823,500$59.4M0.7%0Timeline
NVSTENVISTA HOLDINGS CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 20,167 shares; 2024Q4: 1,018,415 shares; 2025Q1: 2,024,943 shares; 2025Q2: 2,215,845 shares; 2025Q3: 2,294,036 shares; 2025Q4: 2,280,498 shares; 2026Q1: 2,210,100 shares 2,210,100$56.1M0.66%-70,398Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,594,000 shares; 2024Q4: 2,736,000 shares; 2025Q1: 3,267,551 shares; 2025Q2: 3,915,311 shares; 2025Q3: 2,153,043 shares; 2025Q4: 2,153,043 shares; 2026Q1: 1,530,008 shares 1,530,008$51M0.6%-623,035Timeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 233,813 shares; 2026Q1: 304,013 shares 304,013$48.5M0.57%+70,200Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 9,255 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 851,556 shares 851,556$48.1M0.57%newTimeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 593,000 shares; 2025Q1: 593,000 shares; 2025Q2: 653,000 shares; 2025Q3: 572,258 shares; 2025Q4: 561,170 shares; 2026Q1: 561,170 shares 561,170$46.7M0.55%0Timeline
CERTCERTARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,022,616 shares; 2025Q2: 3,926,099 shares; 2025Q3: 6,739,537 shares; 2025Q4: 7,808,605 shares; 2026Q1: 7,808,605 shares 7,808,605$44.5M0.53%0Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,885,446 shares; 2025Q4: 4,885,446 shares; 2026Q1: 4,885,446 shares 4,885,446$43.7M0.52%0Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,023,265 shares; 2024Q4: 600,515 shares; 2025Q1: 782,333 shares; 2025Q2: 919,403 shares; 2025Q3: 919,403 shares; 2025Q4: 511,163 shares; 2026Q1: 657,000 shares 657,000$42M0.5%+145,837Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 747,000 shares; 2025Q2: 970,590 shares; 2025Q3: 970,590 shares; 2025Q4: 970,590 shares; 2026Q1: 970,590 shares 970,590$38.9M0.46%0Timeline
CDNACAREDX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 30,871 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,191,000 shares; 2025Q4: 2,191,000 shares; 2026Q1: 2,191,000 shares 2,191,000$38M0.45%0Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 844,407 shares; 2024Q4: 373,407 shares; 2025Q1: 373,407 shares; 2025Q2: 373,407 shares; 2025Q3: 373,407 shares; 2025Q4: 767,993 shares; 2026Q1: 767,993 shares 767,993$37M0.44%0Timeline
VCYTVERACYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 12,032 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 625,000 shares; 2025Q3: 726,000 shares; 2025Q4: 726,000 shares; 2026Q1: 726,000 shares 726,000$23.4M0.28%0Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 145,000 shares; 2024Q4: 145,191 shares; 2025Q1: 145,000 shares; 2025Q2: 145,000 shares; 2025Q3: 67,935 shares; 2025Q4: 67,935 shares; 2026Q1: 67,935 shares 67,935$22.5M0.27%0Timeline
EMBCEMBECTA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,730,343 shares; 2024Q4: 3,270,535 shares; 2025Q1: 2,720,535 shares; 2025Q2: 2,749,712 shares; 2025Q3: 2,620,421 shares; 2025Q4: 2,752,031 shares; 2026Q1: 2,534,961 shares 2,534,961$22.4M0.26%-217,070Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 549,000 shares 549,000$21M0.25%newTimeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,027,886 shares; 2024Q4: 3,255,514 shares; 2025Q1: 3,255,514 shares; 2025Q2: 3,255,514 shares; 2025Q3: 3,255,514 shares; 2025Q4: 3,649,211 shares; 2026Q1: 4,394,367 shares 4,394,367$21M0.25%+745,156Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 283,000 shares 283,000$20.7M0.24%newTimeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,606,000 shares; 2026Q1: 3,606,000 shares 3,606,000$19.1M0.23%0Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 159,765 shares; 2025Q4: 170,558 shares; 2026Q1: 323,745 shares 323,745$17.7M0.21%+153,187Timeline
KYTXKYVERNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 918,892 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,000,000 shares; 2026Q1: 2,000,000 shares 2,000,000$17.3M0.2%0Timeline
SGPSPYGLASS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 550,000 shares 550,000$14.3M0.17%newTimeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,016,000 shares; 2025Q2: 1,168,415 shares; 2025Q3: 1,168,415 shares; 2025Q4: 938,308 shares; 2026Q1: 1,324,000 shares 1,324,000$13.3M0.16%+385,692Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,386,000 shares; 2025Q3: 5,386,000 shares; 2025Q4: 2,722,165 shares; 2026Q1: 2,722,165 shares 2,722,165$12.2M0.14%0Timeline
STLNSTARLING ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,360,052 shares; 2024Q4: 3,360,052 shares; 2025Q1: 3,360,052 shares; 2025Q2: 3,360,052 shares; 2025Q3: 3,360,052 shares; 2025Q4: 3,360,052 shares; 2026Q1: 3,360,052 shares 3,360,052$10.3M0.12%0Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,280,000 shares; 2024Q4: 3,379,399 shares; 2025Q1: 3,860,839 shares; 2025Q2: 3,855,552 shares; 2025Q3: 2,927,013 shares; 2025Q4: 386,169 shares; 2026Q1: 386,169 shares 386,169$5.49M0.06%0Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 583,913 shares; 2024Q4: 583,913 shares; 2025Q1: 583,913 shares; 2025Q2: 583,913 shares; 2025Q3: 583,913 shares; 2025Q4: 583,913 shares; 2026Q1: 583,913 shares 583,913$3.23M0.04%0Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,055,192 shares; 2024Q4: 1,066,962 shares; 2025Q1: 1,055,192 shares; 2025Q2: 1,055,192 shares; 2025Q3: 1,055,192 shares; 2025Q4: 1,055,192 shares; 2026Q1: 1,055,192 shares 1,055,192$2.27M0.03%0Timeline
NAMSWNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 92,787 shares; 2024Q4: 92,787 shares; 2025Q1: 92,787 shares; 2025Q2: 92,787 shares; 2025Q3: 92,787 shares; 2025Q4: 92,787 shares; 2026Q1: 92,787 shares 92,787$1.86M0.02%0Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 10,332 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,349 shares; 2025Q4: 13,702 shares; 2026Q1: 13,702 shares 13,702$1.1M0.01%0Timeline
PHGEBIOMX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 131,270 shares; 2026Q1: 131,272 shares 131,272$493K0.01%+2Timeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,000 shares 5,000$316K<0.01%newTimeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 917 shares; 2025Q1: 917 shares; 2025Q2: 917 shares; 2025Q3: 917 shares; 2025Q4: 917 shares; 2026Q1: 917 shares 917$159K<0.01%0Timeline
STLNWSTARLING ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,250,000 shares; 2024Q4: 1,250,000 shares; 2025Q1: 1,250,000 shares; 2025Q2: 1,250,000 shares; 2025Q3: 1,250,000 shares; 2025Q4: 1,250,000 shares; 2026Q1: 1,250,000 shares 1,250,000$54.8K<0.01%0Timeline
QSIAWQUANTUM SI INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 333,333 shares; 2024Q4: 333,333 shares; 2025Q1: 333,333 shares; 2025Q2: 333,333 shares; 2025Q3: 333,333 shares; 2025Q4: 333,333 shares; 2026Q1: 333,333 shares 333,333$36.2K<0.01%0Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 8,790 shares; 2025Q3: 8,790 shares; 2025Q4: 8,790 shares; 2026Q1: 8,790 shares 8,790$10.9K<0.01%0Timeline
SRZNWSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 166,666 shares; 2024Q4: 166,666 shares; 2025Q1: 166,666 shares; 2025Q2: 166,666 shares; 2025Q3: 166,666 shares; 2025Q4: 166,666 shares; 2026Q1: 166,666 shares 166,666$2.67K<0.01%0Timeline
MYGNMYRIAD GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 505 shares; 2025Q3: 505 shares; 2025Q4: 505 shares; 2026Q1: 505 shares 505$2.27K<0.01%0Timeline

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
BROOKDALE SR LIVING INCBROOKDALE SR LIVING INC NOTE 3.500%10/1principal306,885,000$505M0
MIRUM PHARMACEUTICALS INCMIRUM PHARMACEUTICALS INC NOTE 4.000% 5/0principal70,000,000$209M0
ARROWHEAD PHARMACEUTICALS INARROWHEAD PHARMACEUTICALS IN Convertibleprincipal200,000,000$207Mnew
IONIS PHARMACEUTICALS INCIONIS PHARMACEUTICALS INC NOTE 1.750% 6/1principal60,000,000$90.6M0
ALIGNMENT HEALTHCARE INCALIGNMENT HEALTHCARE INC NOTE 4.250%11/1principal61,000,000$85.9M0
ZENAS BIOPHARMA INCZENAS BIOPHARMA INC NOTE 2.500% 4/0principal65,000,000$67.3Mnew
NEOGENOMICS INCNEOGENOMICS INC NOTE 0.250% 1/1principal72,689,000$66.7M0
LIVANOVA PLCLIVANOVA PLC NOTE 2.500% 3/1principal34,280,000$40M0
IMMUNOCORE HLDGS PLCIMMUNOCORE HLDGS PLC NOTE 2.500% 2/0principal30,000,000$27M0

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
INDIVIOR PLCINDIVIOR PLC3,393,063$122Mshares
PHRPHREESIA INC1,999,045$33.8Mshares
MRNAMODERNA INC1,000,000$29.5Mput
LANTHEUS HLDGS INCLANTHEUS HLDGS INC25,255,000$28.9Mprincipal
VTRVENTAS INC354,000$27.4Mshares
SYRESPYRE THERAPEUTICS INC710,626$23.3Mshares
EWTXEDGEWISE THERAPEUTICS INC765,694$19Mshares
CRMDCORMEDIX INC1,107,944$12.9Mshares
MDLNMEDLINE INC260,000$10.9Mshares
OMDAOMADA HEALTH INC553,107$8.73Mshares
CALCCALCIMEDICA INC1,300,000$8.57Mshares
PBHPRESTIGE CONSMR HEALTHCARE I69,669$4.3Mshares
VEEVVEEVA SYS INC17,711$3.95Mshares
RDNTRADNET INC49,951$3.56Mshares
LHLABCORP HOLDINGS INC13,825$3.47Mshares
ENOVENOVIS CORPORATION127,270$3.39Mshares
ALHCALIGNMENT HEALTHCARE INC164,345$3.25Mshares
DGXQUEST DIAGNOSTICS INC18,392$3.19Mshares
TMDXTRANSMEDICS GROUP INC25,492$3.1Mshares
PODDINSULET CORP10,616$3.02Mshares
BLFSBIOLIFE SOLUTIONS INC120,211$2.91Mshares
CHECHEMED CORP NEW6,215$2.66Mshares
WOOFPETCO HEALTH & WELLNESS CO I936,309$2.63Mshares
KIDSORTHOPEDIATRICS CORP144,220$2.56Mshares
CITHE CIGNA GROUP9,203$2.53Mshares
TRUPTRUPANION INC66,438$2.48Mshares
RMDRESMED INC10,104$2.43Mshares
BSXBOSTON SCIENTIFIC CORP24,941$2.38Mshares
DVADAVITA INC20,909$2.38Mshares
DOCSDOXIMITY INC51,942$2.3Mshares
DXCMDEXCOM INC32,943$2.19Mshares
IRTCIRHYTHM HOLDINGS INC12,099$2.15Mshares
CNMDCONMED CORP52,555$2.13Mshares
MASIMASIMO CORP16,147$2.1Mshares
LMATLEMAITRE VASCULAR INC25,815$2.09Mshares
TXG10X GENOMICS INC126,574$2.06Mshares
ATRCATRICURE INC52,076$2.06Mshares
AVNSAVANOS MED INC167,061$1.88Mshares
CRVLCORVEL CORP27,629$1.87Mshares
CAHCARDINAL HEALTH INC8,985$1.85Mshares
GDRXGOODRX HLDGS INC660,133$1.79Mshares
SGRYSURGERY PARTNERS INC112,623$1.74Mshares
ALGNALIGN TECHNOLOGY INC11,000$1.72Mshares
ADUSADDUS HOMECARE CORP15,871$1.7Mshares
MMSIMERIT MED SYS INC18,798$1.66Mshares
NHCNATIONAL HEALTHCARE CORP12,085$1.66Mshares
EHCENCOMPASS HEALTH CORP15,259$1.62Mshares
VREXVAREX IMAGING CORP131,745$1.53Mshares
HQYHEALTHEQUITY INC16,231$1.49Mshares
ABTABBOTT LABORATORIES11,449$1.43Mshares
MMSMAXIMUS INC16,606$1.43Mshares
SYKSTRYKER CORPORATION3,551$1.25Mshares
ATECALPHATEC HLDGS INC57,277$1.21Mshares
STAASTAAR SURGICAL CO51,894$1.2Mshares
UFPTUFP TECHNOLOGIES INC5,098$1.13Mshares
KVUEKENVUE INC65,344$1.13Mshares
MDXGMIMEDX GROUP INC160,419$1.09Mshares
ITGRINTEGER HLDGS CORP13,326$1.05Mshares
RVTYREVVITY INC10,323$999Kshares
AZTAAZENTA INC25,835$859Kshares
ARVNARVINAS INC68,057$807Kshares
ZTSZOETIS INC5,698$717Kshares
COOCOOPER COS INC7,786$638Kshares
SDGRSCHRODINGER INC33,987$608Kshares
TNDMTANDEM DIABETES CARE INC26,090$573Kshares
RXSTRXSIGHT INC52,257$545Kshares
IARTINTEGRA LIFESCIENCES HLDGS C39,209$487Kshares
ABBVABBVIE INC2,014$460Kshares
HROWHARROW INC8,693$426Kshares
XERSXERIS BIOPHARMA HOLDINGS INC52,230$410Kshares
HCSGHEALTHCARE SVCS GROUP INC21,259$406Kshares
AMPHAMPHASTAR PHARMACEUTICALS IN14,852$398Kshares
RGENREPLIGEN CORP2,199$360Kshares
STESTERIS PLC1,352$343Kshares
BRBRBELLRING BRANDS INC11,996$321Kshares
ISRGINTUITIVE SURGICAL INC483$274Kshares
EYENATIONAL VISION HLDGS INC10,284$266Kshares
ABEOABEONA THERAPEUTICS INC40,000$211Kshares
NUVATION BIO INCNUVATION BIO INC166,666$55Kshares
BUTTERFLY NETWORK INCBUTTERFLY NETWORK INC733,333$12.9Kshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001213900-26-057678 base2026-05-15acceptance time not in the bulk data set